130 related articles for article (PubMed ID: 16273213)
1. A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing.
Uhmann A; Ferch U; Bauer R; Tauber S; Arziman Z; Chen C; Hemmerlein B; Wojnowski L; Hahn H
Int J Oncol; 2005 Dec; 27(6):1567-75. PubMed ID: 16273213
[TBL] [Abstract][Full Text] [Related]
2. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site.
Agren M; Kogerman P; Kleman MI; Wessling M; Toftgård R
Gene; 2004 Apr; 330():101-14. PubMed ID: 15087129
[TBL] [Abstract][Full Text] [Related]
3. Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein.
Kogerman P; Krause D; Rahnama F; Kogerman L; Undén AB; Zaphiropoulos PG; Toftgård R
Oncogene; 2002 Sep; 21(39):6007-16. PubMed ID: 12203113
[TBL] [Abstract][Full Text] [Related]
4. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched.
Wetmore C; Eberhart DE; Curran T
Cancer Res; 2000 Apr; 60(8):2239-46. PubMed ID: 10786690
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GLI1 gene activation by Patched1.
Rahnama F; Shimokawa T; Lauth M; Finta C; Kogerman P; Teglund S; Toftgård R; Zaphiropoulos PG
Biochem J; 2006 Feb; 394(Pt 1):19-26. PubMed ID: 16229683
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons.
Nagao K; Toyoda M; Takeuchi-Inoue K; Fujii K; Yamada M; Miyashita T
Genomics; 2005 Apr; 85(4):462-71. PubMed ID: 15780749
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of first exon variants of the tumor-suppressor Patched1 in Hedgehog signaling.
Shimokawa T; Svärd J; Heby-Henricson K; Teglund S; Toftgård R; Zaphiropoulos PG
Oncogene; 2007 Jul; 26(34):4889-96. PubMed ID: 17310997
[TBL] [Abstract][Full Text] [Related]
9. The hedgehog-patched signaling pathway and function in the mammalian ovary: a novel role for hedgehog proteins in stimulating proliferation and steroidogenesis of theca cells.
Spicer LJ; Sudo S; Aad PY; Wang LS; Chun SY; Ben-Shlomo I; Klein C; Hsueh AJ
Reproduction; 2009 Aug; 138(2):329-39. PubMed ID: 19433502
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of PTCH2 splice variants in Hedgehog signalling.
Rahnama F; Toftgård R; Zaphiropoulos PG
Biochem J; 2004 Mar; 378(Pt 2):325-34. PubMed ID: 14613484
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice.
Eichenmüller M; Bauer R; Von Schweinitz D; Hahn H; Kappler R
Int J Oncol; 2007 Aug; 31(2):405-12. PubMed ID: 17611698
[TBL] [Abstract][Full Text] [Related]
12. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
13. Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431.
Koike C; Mizutani T; Ito T; Shimizu Y; Yamamichi N; Kameda T; Michimukai E; Kitamura N; Okamoto T; Iba H
Oncogene; 2002 Apr; 21(17):2670-8. PubMed ID: 11965540
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines.
Thievessen I; Wolter M; Prior A; Seifert HH; Schulz WA
J Cell Physiol; 2005 May; 203(2):372-7. PubMed ID: 15521068
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the PTCH1 signaling pathway in ovarian dermoids.
Levanat S; Kappler R; Hemmerlein B; Döring P; Musani V; Komar A; Oreskovic S; Pavelic B; Hahn H
Int J Mol Med; 2004 Nov; 14(5):793-9. PubMed ID: 15492847
[TBL] [Abstract][Full Text] [Related]
16. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.
Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H
Oncogene; 2004 Nov; 23(54):8785-95. PubMed ID: 15480423
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.
Svärd J; Rozell B; Toftgård R; Teglund S
Mol Carcinog; 2009 May; 48(5):408-19. PubMed ID: 18781608
[TBL] [Abstract][Full Text] [Related]
18. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
[TBL] [Abstract][Full Text] [Related]
19. The Shh signalling pathway in early tooth development.
Hardcastle Z; Hui CC; Sharpe PT
Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):567-78. PubMed ID: 10512189
[TBL] [Abstract][Full Text] [Related]
20. Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas.
Pritchard JI; Olson JM
Cancer Genet Cytogenet; 2008 Jan; 180(1):47-50. PubMed ID: 18068533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
